August, 2009LexisNexis® Legal News Podcast for August 24, 2009
A $125 million settlement is reached in a Bristol-Myers securities class action, and, a Viagra vision MDL is “effectively ended” with the exclusion of a general causation expert. Hear these and other stories from LexisNexis® Mealey’s™ Publications. Copyright© 2009 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.
Steam Dietary Supplement
Audience: Consumers, pharmacists
[UPDATED 08/24/2009] Nutracoastal has found by lab analysis that Lot 90260 contains Tadalafil, an active ingredient of an FDA-approved drug for erectile dysfunction, making Steam an unapproved drug. The lot number…
Orlistat (marketed as Alli and Xenical): Early Communication about an Ongoing Safety Review
Audience: Endocrinological healthcare professionals, patients
FDA notified healthcare professionals and patients that it is reviewing new safety information regarding reports of liver-related adverse events in patients taking orlistat. Orlistat…
Accusure Insulin Syringes [31G, 1/2 cc and 1 cc]
Audience: Patients with diabetes mellitus, pharmacists and diabetes healthcare professionals Qualitest Pharmaceuticals and FDA notified patients and healthcare professionals of a voluntary nationwide recall of two lots of Accusure Insulin…
Flu Drugs Tamiflu, Relenza Called ‘Ineffective’ for Adults
As health officials around the world brace for the expected arrival of a worse-than-normal fall and winter flu season powered by the potentially fatal H1N1 “Swine Flu” influenza virus, British researchers say two flu drugs should not be used to treat healthy adults stricken with the illness.
Continue →MRSA: Drug-Resistant “Super Bug” Blamed for Life-Threatening Infections
Methicillin-resistant Staphylococcus aureus (MRSA) is a form of bacterial staph infection, a potentially deadly and drug-resistant “Superbug” that cannot be controlled with common antibiotics. About 90,000 serious infections and 18,000 deaths in the United States are blamed on MRSA every year, according to the Centers for Disease Control and Prevention. The infections also are spreading faster and in more locations than it had previously.
Continue →FDA Approves Sabril for Infantile Spasms, Adult Epileptic Seizures
Sabril has become the first approved drug for the treatment of infantile spasms, a debilitating disorder that produces frequent and hard-to-control seizures in newborns and young babies, as well as adult seizures caused by epilepsy.
Continue →Lilly Settles Zyprexa Suit in W.V. for $22.5 Million
Eli Lilly & Co. is breaking out the corporate checkbook again to settle legal claims that it illegally marketed its blockbuster antipsychotic drug Zyprexa.
Continue →Lead Dust on Vehicle Safety Seats a Risk to Kids, Researchers Say
Lead dust and particles tracked into vehicles by parents who carry the toxic materials home from work can end up on a child safety seat and expose children to increased risks of brain and kidney damage and other severe complications, according to a new government study.
Continue →LexisNexis® Legal News Podcast for August 21, 2009
The 9th Circuit overturns a backdating conviction against a CEO for prosecutorial misconduct, and, a federal judge revives Congoleum Corp.’s bankruptcy. Hear these and other stories from LexisNexis® Mealey’s™ Publications. Copyright© 2009 LexisNexis, a division of Reed Elsevier Inc. For the latest litigation news headlines, visit www.lexisnexis.com/mealeys.
Recent Related Features
All Stories
facebook
rss
twitter